edotreotide has been researched along with glucagon-like peptide 1 in 1 studies
Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
---|---|---|---|---|---|
206 | 34 | 86 | 9,484 | 1,208 | 6,374 |
Protein | Taxonomy | edotreotide (IC50) | glucagon-like peptide 1 (IC50) |
---|---|---|---|
Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breeman, WA; Sims-Mourtada, J; Smith, DL | 1 |
1 other study(ies) available for edotreotide and glucagon-like peptide 1
Article | Year |
---|---|
The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.
Topics: Amine Oxidase (Copper-Containing); Cell Adhesion Molecules; Gallium Radioisotopes; Glucagon-Like Peptide 1; Half-Life; Insulinoma; Neuroendocrine Tumors; Octreotide; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Radionuclide Generators; Radiopharmaceuticals; Receptors, Bombesin; Receptors, Somatostatin; Single-Domain Antibodies; Somatostatin; Vascular Endothelial Growth Factor A | 2013 |